Medical Device Webinars, News & Regulatory Info

Cytotoxicity, Sensitization & Irritation Testing – The Big Three – Webinar w/ Thor Rollins

Cytotoxicity, Sensitization & Irritation Testing – The Big Three – Webinar w/ Thor Rollins

Celegence Admin2021-12-15T19:39:11+00:00December 15th, 2021|

Post Market Surveillance Under the EU MDR – Webinar Transcript – Q&A

Post Market Surveillance Under the EU MDR – Webinar Transcript – Q&A

Celegence2021-12-08T17:41:05+00:00December 8th, 2021|

Post Market Surveillance Under the EU MDR – Webinar Transcript – Part 2

Post Market Surveillance Under the EU MDR – Webinar Transcript – Part 2

Celegence2021-11-30T16:24:39+00:00November 30th, 2021|

Post Market Surveillance Under the EU MDR – Webinar Transcript – Part 1

Post Market Surveillance Under the EU MDR – Webinar Transcript – Part 1

Celegence Admin2021-11-23T17:51:42+00:00November 23rd, 2021|

Beyond Compliance: Preparing for IDMP Now and Into the Future

Beyond Compliance: Preparing for IDMP Now and Into the Future

Celegence2021-12-08T16:03:41+00:00November 16th, 2021|

Medical Device Software Compliance under EU Regulations 2017/745 and 2017/746 – Q&A

Medical Device Software Compliance under EU Regulations 2017/745 and 2017/746 – Q&A

Celegence2021-11-02T15:38:33+00:00November 2nd, 2021|

Medical Device Software Compliance under EU Regulations 2017/745 and 2017/746 – Webinar

Medical Device Software Compliance under EU Regulations 2017/745 and 2017/746 – Webinar

Celegence Admin2021-10-28T15:35:19+00:00October 28th, 2021|

Ensuring Compliance For Your IVD’s Performance Evaluation – Webinar

Ensuring Compliance For Your IVD’s Performance Evaluation – Webinar

Celegence2021-10-12T16:38:16+00:00October 12th, 2021|

Medical Device Software Compliance under EU Regulations 2017/745 and 2017/746 – Webinar

Medical Device Software Compliance under EU Regulations 2017/745 and 2017/746 – Webinar

Celegence2021-10-05T15:44:13+00:00October 5th, 2021|

Combination Products: Seeking a Notified Body Opinion according to MDR Article 117 – Transcript – Q&A

Combination Products: Seeking a Notified Body Opinion according to MDR Article 117 – Transcript – Q&A

Celegence2021-09-22T11:52:32+00:00September 22nd, 2021|

Medical Device Webinars

Cytotoxicity, Sensitization & Irritation Testing – The Big Three – Webinar w/ Thor Rollins

Cytotoxicity, Sensitization & Irritation Testing – The Big Three – Webinar w/ Thor Rollins

Post Market Surveillance Under the EU MDR – Webinar Transcript – Q&A

Post Market Surveillance Under the EU MDR – Webinar Transcript – Q&A

Post Market Surveillance Under the EU MDR – Webinar Transcript – Part 2

Post Market Surveillance Under the EU MDR – Webinar Transcript – Part 2

Post Market Surveillance Under the EU MDR – Webinar Transcript – Part 1

Post Market Surveillance Under the EU MDR – Webinar Transcript – Part 1

Beyond Compliance: Preparing for IDMP Now and Into the Future

Beyond Compliance: Preparing for IDMP Now and Into the Future

Medical Device Software Compliance under EU Regulations 2017/745 and 2017/746 – Q&A

Medical Device Software Compliance under EU Regulations 2017/745 and 2017/746 – Q&A

Medical Device Software Compliance under EU Regulations 2017/745 and 2017/746 – Webinar

Medical Device Software Compliance under EU Regulations 2017/745 and 2017/746 – Webinar

Ensuring Compliance For Your IVD’s Performance Evaluation – Webinar

Ensuring Compliance For Your IVD’s Performance Evaluation – Webinar

Medical Device Software Compliance under EU Regulations 2017/745 and 2017/746 – Webinar

Medical Device Software Compliance under EU Regulations 2017/745 and 2017/746 – Webinar

Combination Products: Seeking a Notified Body Opinion according to MDR Article 117 – Transcript – Q&A

Combination Products: Seeking a Notified Body Opinion according to MDR Article 117 – Transcript – Q&A

Medical Device Resources

Pharmaceutical Resources

Schedule A Demo

Our Services

Brexit Whitepaper